See inside every stock. Pro
S&P 5007,757▲ 0.58%Nasdaq26,703▲ 1.05%Dow Jones52,856▲ 0.69%Nasdaq 10029,823▲ 1.13%VIX16.68▼ 3.64%US Dollar101.69▼ 0.01%Gold spot4,114▼ 0.44%WTI99.97▲ 2.90%
← TRN page
XStocksXray
Market X-Ray report · 21 October 2026

Trainline Plc (TRN)

London Exchange · UK · prices in GBX · close of 21 Oct 2026

Key indicators

Last closeGBX 222.20
52-week range178.00 – 283.80
Return, 1 month / 3 months+13.0% / +3.9%
Return, 1 year / 3 years−14.9% / −6.2%
TrendUptrend
RSI (14)62
Volatility (1 year)39.0%
Worst drawdown (1 year)-31.6%
Average daily value traded438.26M GBX
Dividend yield–

Market X-Ray price-based

51/ 100 · High confidence · ahead of 47% of stocks on this exchange
Trend46
Momentum37
Stability (higher is calmer)44
Liquidity95
Income–

Five-year price chart navy: price · brown: 200-day average

1422202973744512021-102023-012024-042025-072026-10

About the company

Trainline is a digital platform for booking rail and coach travel, based in London. Through its app and website, travellers compare journeys and purchase tickets for many different train operators, mainly in Britain and across parts of Europe. The company also supplies its booking technology to rail operators and travel businesses, and it earns money from commissions and booking fees on the tickets it handles. Its customers are individual travellers as well as corporate and partner organisations.

On this site Trainline Plc appears as a stock on the London Exchange (UK), code TRN, with prices in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Trainline Plc (TRN) trades on the London Exchange in UK. It last closed at GBX 222.20 on 21 October 2026.

Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 1,991 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 14.9% and over the last three months it rose 3.9%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Trainline Plc (TRN)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend46 · WeakBelow its long-term averages and far from its highs.
Above 200-day average3.5%
From 52-week high-18.1%
Momentum37 · WeakLagging most stocks on this exchange.
3-month return3.9%
6-month return-9.8%
12-month return, skipping the last month-24.6%
Stability (higher is calmer)44 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)39.0%
Worst drawdown, 1 year (smaller is calmer)-31.6%
Liquidity95 · StrongTrades actively.
Average daily value traded438.26M GBX
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week+7.8%
1 month+13.0%
3 months+3.9%
6 months−9.8%
1 year−14.9%
3 years−6.2%
5 years−29.9%

Signals

50-day / 200-day average204.79 / 214.66
Golden / death cross (60 days)Death, 17 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)9.69

Technical summary

DailyStrongly bullish12 bullish · 3 neutral · 1 bearish
WeeklyNeutral5 bullish · 1 neutral · 6 bearish
MonthlyBearish2 bullish · 1 neutral · 5 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 22 Oct 2026